Chemours
Maker of refrigerants, Ti-Pure pigment, and high-performance fluoromaterials for industrial markets.
Something off on this page? Send us feedback.
Profile
Sells refrigerants and thermal-management fluids, Ti-Pure titanium dioxide pigment, and Teflon, Viton, Nafion, and Krytox fluoromaterials through three global segments. Demand and product mix are shaped by cooling regulations, industrial cycles, and legacy environmental obligations shared in part with DuPont and Corteva.
Produces refrigerants and thermal-management fluids, titanium dioxide pigment, and high-performance fluoromaterials through Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. Opteon and Freon serve cooling and related uses; Ti-Pure provides whiteness and opacity for coatings, plastics, laminates, and paper; Teflon, Viton, Nafion, and Krytox serve demanding industrial, electronics, transportation, energy, and chemical-processing applications.
Runs a global manufacturing and technical network, with proprietary process chemistry, application development, and reliable production supporting customer-specific performance requirements. The refrigerants portfolio is shifting from Freon products toward lower-global-warming-potential Opteon products as climate regulations phase down hydrofluorocarbons.
Operates under evolving chemicals and emissions rules, while legacy environmental remediation and PFAS liabilities remain partly governed by separation agreements and a cost-sharing arrangement with DuPont and Corteva.
Company facts
Key statistics
Year to date +27.6% · Average volume (30d) 2.6M
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Prior rating | Rating | Prior target | Target |
|---|---|---|---|---|---|---|
| Aug 13, 2026 | BMO Capital | Reiterate | Outperform | $19 | $18 | |
| Aug 13, 2026 | Goldman Sachs | Reiterate | Neutral | $17 | ||
| Aug 10, 2026 | Morgan Stanley | Target | $21 | $18 | ||
| Aug 10, 2026 | UBS | Downgrade | Buy | Neutral | $30 | $18 |
| Aug 6, 2026 | RBC Capital | Reiterate | Outperform | $29 | $22 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Aug 4, 2026Q2 FY26 | $0.49 | $0.42 | −14.1% | $1.65B | $1.59B | −3.6% | −18.63% |
| May 5, 2026Q1 FY26 | −$0.05 | $0.05 | +200.0% | $1.40B | $1.38B | −1.3% | −15.28% |
| Feb 19, 2026Q4 FY25 | $0.09 | $0.05 | −43.6% | $1.33B | $1.33B | 0.0% | −16.51% |
| Nov 6, 2025Q3 FY25 | $0.24 | $0.20 | −16.7% | $1.33B | $1.50B | +12.5% | +6.56% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $1.37B | $1.62B | $1.50B | $1.33B | $1.38B | $1.59B | |
| Gross profit | $236.0M | $278.0M | $235.0M | $153.0M | $215.0M | $286.0M | |
| Operating income | $78.0M | $72.0M | $104.0M | −$259.0M | $64.0M | −$213.0M | |
| Net income | −$4.0M | −$381.0M | $60.0M | −$61.0M | −$29.0M | −$274.0M | |
| Diluted EPS | −$0.03 | −$2.54 | $0.40 | −$0.39 | −$0.19 | −$1.81 | |
| Gross margin | 17.3% | 17.2% | 15.7% | 11.5% | 15.6% | 18.0% | |
| Operating margin | 5.7% | 4.5% | 7.0% | -19.5% | 4.6% | -13.4% |
Fiscal years (4-quarter sums)FY21 $6.35B · FY22 $6.79B · FY23 $6.08B · FY24 $5.81B · FY25 $5.81B
Revenue by product · Q2 FY26
Revenue by geography · FY25
Balance sheet, Jun 30, 2026Cash & short-term investments $671.0M · Total debt $4.12B · Total assets $7.15B · Shareholders' equity −$49.0M
Dividends
Last cut to $0.0875 from $0.25 in May 2025. To collect a payout, hold shares through the close before the ex-date.
History
| Ex-date | Record | Paid | Amount | Note |
|---|---|---|---|---|
| Aug 14, 2026 | Aug 14 | Sep 15 | $0.0875 | |
| May 15, 2026 | May 17 | Jun 16 | $0.0875 | |
| Feb 27, 2026 | Feb 27 | Mar 13 | $0.0875 | |
| Nov 14, 2025 | Nov 14 | Dec 15 | $0.0875 | |
| Aug 15, 2025 | Aug 15 | Sep 12 | $0.0875 | |
| May 16, 2025 | May 17 | Jun 16 | $0.0875 | cut from $0.25 |
| Feb 28, 2025 | Feb 28 | Mar 14 | $0.25 | |
| Nov 15, 2024 | Nov 15 | Dec 16 | $0.25 |
Ownership
Shares outstanding 150.38M · Float 148.91M · 99.0% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 23.28M | 15.48% | 13F | Aug 7, 2026 |
| Vanguard Portfolio Management LLC | 10.57M | 7.03% | 13F | Aug 13, 2026 |
| Millennium Management LLC | 7.58M | 5.10% | 13G | Aug 8, 2025 |
| Vanguard Capital Management LLC | 6.78M | 4.51% | 13F | Aug 13, 2026 |
| State Street Corp | 6.12M | 4.07% | 13F | Aug 7, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 12, 2026 | Calderon Gerardo Familiar | officer: See Remarks | +1,935 | $15.53 |
| Aug 11, 2026 | Denise Dignam | director, officer: Chief Executive Officer | +3,378 | $14.95 |
| Aug 7, 2026 | Joseph T. Martinko | officer: See Remarks | +1,940 | $15.47 |
| Aug 7, 2026 | Mary B. Cranston | director | +6,000 | $15.83 |
| Aug 7, 2026 | Alister Cowan | director | +13,000 | $15.62 |
Peers
- Solstice Advanced Materials
Direct Opteon rival in low-GWP refrigerants and applied solutions
- Tronox
Vertically integrated TiO2 pigment rival
- Kronos Worldwide
TiO2 pure-play rival in coatings, plastics, and paper
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Chemours | $15.70 | +0.45% | $2.35B | — | 10.3 | 0.4 | −1.5% |
| Solstice Advanced Materials | $63.90 | +0.55% | $10.09B | 48.1 | 20.4 | 2.5 | — |
| Tronox | $5.50 | +2.04% | $861.4M | — | — | 0.3 | +18.7% |
| Kronos Worldwide | $8.80 | −0.05% | $1.01B | — | 14.8 | 0.5 | +12.9% |
| Median | 48.1 | 17.6 | 0.5 | +15.8% |